- Stakeholders in the healthcare sector have pledged to fight AMR, which claims 1.27 million lives yearly.
- AMR threatens modern medicine, compromising the treatment of simple infections and affecting food security, economic stability, and human, animal, and environmental well-being.
- The World Health Organization (WHO) emphasizes the need for intersectoral collaboration and a One Health approach to address AMR.
The alarming rise of Anti-Microbial Resistance (AMR) has prompted stakeholders in the healthcare sector to unite in the fight against this growing threat. AMR occurs when microorganisms evolve to resist drugs designed to kill them, leading to 1.27 million deaths annually and over 4.95 million deaths linked to resistant infections.
Experts warn that AMR threatens the foundations of modern medicine, compromising the treatment of simple infections and having far-reaching consequences for food security, economic stability, and human, animal, and environmental well-being.
To combat AMR, stakeholders emphasize the importance of intersectoral collaboration and a One Health approach, which involves coordinating multiple sectors and stakeholders engaged in human, animal, and plant health, food and feed production, and the environment.
The WHO’s global action plan on antimicrobial resistance provides a framework to guide the development and implementation of national multisectoral plans, emphasizing the need for intersectoral collaboration and a One Health approach.
By working together, stakeholders can raise awareness, promote responsible antimicrobial use, and drive policy change to combat the growing threat of AMR.
